Proton therapy and heavy ion therapy are the two market segments for particle therapy. In 2021, the sector for proton therapy had the biggest market share (85.7%). Large portions of this market can be attributed to elements like increased radiation dose, increased precision, quicker treatment periods, and reduced side effects as compared to conventional X-ray photon therapy. Lung cancer, bladder cancer, tumours of the brain and spinal cord, and other diseases are included in the segments of the particle therapy market. The market for the brain and spinal cord was valued at USD 107 million in 2021, and from 2022 to 2029, it is anticipated to increase at a CAGR of %. During the prediction period, the Brain and Spinal Cord Cancer (BSCT) sector is anticipated to hold a sizable portion of the global particle treatment market.
read more..